Alpha Diagnostic International, Inc. Anti-Mouse Agouti antiserum AGO11-S

Anti-Mouse Agouti antiserum General Information Several common diseases such as type II diabetes, hypertension, cardiovascular diseases, hyperlipidemia, and some cancers are associated with obesity. An abnormal increase in body fat relative to lean tissue mass has been used as an indicator of obesity. SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Mouse SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Antiserum Unpurified SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 21aa peptide of Mouse Agouti (1); Designated (AGO11-P or control peptide /blocking peptide) conjugated to KLH; Epitope location ~ N-terminus SpCrossreactivity Mouse AGO11-P peptide is 80% conserved in human, 73% in pig, 75% in fox. 6-% in bovine agouti proteins. No homology is seen with AGRP, tubby, tub, TULP1, and TULP2. Antibody crossreactivity in various species is not known. For research use only, not for diagnostic or therapeutic use.